Gene · 23642
Papers1,503
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,503
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long non-coding RNAs and JAK/STAT signaling pathway regulation in colorectal cancer development. | Front Genet | 2023 | 38094755 | PubTator, text mining | PubMed |
| Long non-coding RNA and Evolving drug resistance in lung cancer. | Heliyon | 2023 | 38089985 | PubTator, text mining | PubMed |
| Deregulated Long Non-Coding RNA HCG11 in Cerebral Atherosclerosis Serves as a Biomarker to Predict the Risk of Cerebrovascular Events. | Clin Appl Thromb Hemost | 2023 | 38082538 | PubTator, text mining | PubMed |
| Epigenetic Dysregulation in MYCN-Amplified Neuroblastoma. | Int J Mol Sci | 2023 | 38069407 | PubTator, text mining | PubMed |
| [Research Progress of LncRNA SNHGs in Regulating the Biological Behavior of Non-small Cell Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2023 | 38061887 | PubTator, text mining | PubMed |
| Exploring the expression of SNHG1 and its effect on the PI3K-AKT axis in nasopharyngeal cancer. | Neoplasma | 2023 | 38053377 | PubTator, text mining | PubMed |
| Novel pyroptosis-related lncRNAs and ceRNAs predict osteosarcoma prognosis and indicate immune microenvironment signatures. | Heliyon | 2023 | 38027935 | PubTator, text mining | PubMed |
| The ideal treatment timing for diabetic retinopathy: the molecular pathological mechanisms underlying early-stage diabetic retinopathy are a matter of concern. | Front Endocrinol (Lausanne) | 2023 | 38027131 | PubTator, text mining | PubMed |
| Analysis of Nucleoporin 107 Overexpression and Its Association with Prognosis and Immune Infiltration in Lung Adenocarcinoma by Bioinformatics Methods. | Int J Gen Med | 2023 | 38021066 | PubTator, text mining | PubMed |
| Characterization of lncRNA-associated ceRNA network to uncover novel potential biomarkers in coronary artery disease. | Medicine (Baltimore) | 2023 | 38013355 | PubTator, text mining | PubMed |
| Changes in the small noncoding RNA transcriptome in osteosarcoma cells. | J Orthop Surg Res | 2023 | 38001513 | PubTator, text mining | PubMed |
| An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer. | Noncoding RNA | 2023 | 37987366 | PubTator, text mining | PubMed |
| From multi-omics approaches to personalized medicine in myocardial infarction. | Front Cardiovasc Med | 2023 | 37965091 | PubTator, text mining | PubMed |
| LncRNA WAC-AS1 promotes osteosarcoma Metastasis and stemness by sponging miR-5047 to upregulate SOX2. | Biol Direct | 2023 | 37957698 | PubTator, text mining | PubMed |
| SNHG1/miR-21 axis mediates the cardioprotective role of aloin in sepsis through modulating cardiac cell viability and inflammatory responses. | J Clin Lab Anal | 2023 | 37950500 | PubTator, text mining | PubMed |
| The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases. | Cells | 2023 | 37947606 | PubTator, text mining | PubMed |
| Identification and development of TP53 mutation-associated Long non-coding RNAs signature for optimized prognosis assessment and treatment selection in hepatocellular carcinoma. | Int J Immunopathol Pharmacol | 2023 | 37942552 | PubTator, text mining | PubMed |
| Systematic analysis reveals a pan-cancer SNHG family signature predicting prognosis and immunotherapy response. | iScience | 2023 | 37854704 | PubTator, text mining | PubMed |
| Exploring the Potential of Non-Coding RNAs as Liquid Biopsy Biomarkers for Lung Cancer Screening: A Literature Review. | Cancers (Basel) | 2023 | 37835468 | PubTator, text mining | PubMed |
| Unlocking the role of non-coding RNAs in prostate cancer progression: exploring the interplay with the Wnt signaling pathway. | Front Pharmacol | 2023 | 37829301 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23642/papers?page=8